January 16, 2025

Algorithm Improves Diagnosis of Uterine Lesions

"The preoperative 3-class diagnostic algorithm and risk class system can stratify women according to risk of malignancy."

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 13, 2025

Boosting Primary Care: Medical School Strategies

"It’s not the medical schools that are the problem; it’s the job. The job is too toxic.”

KFF Health News

January 08, 2025

More Archetypes to Guide OUD Discussions

Discover how a six-archetype framework enhances clinician communication, care, and decision-making for patients with opioid use disorder.

Conexiant

May 08, 2024

ObGyn Harassment Prevalence Exposed in Revealing Review

Discover key insights from a systematic review on harassment among ObGyn health care professionals.

Conexiant

November 14, 2024

Can Botox Ease Chronic Pelvic Pain?

A recent study assessed the efficacy of Botulinum Toxin A injections in conjunction with pelvic floor muscle therapy for women with chronic pelvic pain, revealing interesting insights into its effectiveness compared to a placebo.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant

November 19, 2024

Does Tetracycline Use in Pregnancy Affect Birth Defects?

A recent study in the Swedish population found no increased risk of major congenital malformations associated with tetracycline use during the first trimester of pregnancy. Further research may help clarify potential risks for specific malformation subgroups.

Conexiant

June 13, 2024

Role of Embryo Freezing in IVF: An Explainer

In 2021, over 80% of U.S. in vitro fertilization procedures involved the transfer of frozen embryos, potentially reducing uncertainties, delays, and costs in comparison to fresh embryos.

Reuters